Dayton, NJ, United States of America

Feng Peng

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feng Peng. Retrieved from https://idiyas.com/inventor/feng-peng-4xbx4rvg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Feng Peng

Introduction

Feng Peng is an accomplished inventor based in Dayton, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of fluorinated nucleotides. His work has implications for various applications in pharmaceuticals and biotechnology.

Latest Patents

Feng Peng holds a patent for the "Synthesis of Fluorinated Nucleotides." This innovative process enhances the efficiency and effectiveness of nucleotide synthesis, which is crucial for developing new therapeutic agents.

Career Highlights

Feng Peng is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His role involves research and development, where he applies his expertise to advance the company's pharmaceutical innovations.

Collaborations

Feng has collaborated with notable colleagues, including Jeffrey C. Moore and Heather Claire Johnson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Feng Peng's contributions to the field of biochemistry and his patent for the synthesis of fluorinated nucleotides highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence advancements in healthcare and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…